Annual Total Long Term Liabilities
$84.12 M
-$60.05 M-41.65%
December 31, 2024
Summary
- As of March 12, 2025, ADMA annual total long term liabilities is $84.12 million, with the most recent change of -$60.05 million (-41.65%) on December 31, 2024.
- During the last 3 years, ADMA annual total long term liabilities has fallen by -$20.58 million (-19.66%).
- ADMA annual total long term liabilities is now -46.50% below its all-time high of $157.22 million, reached on December 31, 2022.
Performance
ADMA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$84.12 M
-$29.72 M-26.11%
December 31, 2024
Summary
- As of March 12, 2025, ADMA quarterly total long term liabilities is $84.12 million, with the most recent change of -$29.72 million (-26.11%) on December 31, 2024.
- Over the past year, ADMA quarterly long term liabilities has stayed the same.
- ADMA quarterly long term liabilities is now -46.90% below its all-time high of $158.41 million, reached on March 31, 2023.
Performance
ADMA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ADMA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.6% | 0.0% |
| 3 y3 years | -19.7% | 0.0% |
| 5 y5 years | -3.2% | 0.0% |
ADMA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.5% | at low | -46.9% | at low |
| 5 y | 5-year | -46.5% | at low | -46.9% | at low |
| alltime | all time | -46.5% | -100.0% | -46.9% | -100.0% |
ADMA Biologics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $84.12 M(-41.7%) | $84.12 M(-26.1%) |
| Sep 2024 | - | $113.84 M(-20.9%) |
| Jun 2024 | - | $143.95 M(-0.1%) |
| Mar 2024 | - | $144.08 M(-0.1%) |
| Dec 2023 | $144.17 M(-8.3%) | $144.17 M(-7.4%) |
| Sep 2023 | - | $155.72 M(+0.9%) |
| Jun 2023 | - | $154.31 M(-2.6%) |
| Mar 2023 | - | $158.41 M(+0.8%) |
| Dec 2022 | $157.22 M(+50.2%) | $157.22 M(+1.0%) |
| Sep 2022 | - | $155.73 M(+0.8%) |
| Jun 2022 | - | $154.46 M(+3.3%) |
| Mar 2022 | - | $149.53 M(+42.8%) |
| Dec 2021 | $104.70 M(+5.3%) | $104.70 M(+1.1%) |
| Sep 2021 | - | $103.52 M(+0.5%) |
| Jun 2021 | - | $103.03 M(+1.1%) |
| Mar 2021 | - | $101.96 M(+2.5%) |
| Dec 2020 | $99.48 M(+14.5%) | $99.48 M(-2.6%) |
| Sep 2020 | - | $102.13 M(+0.3%) |
| Jun 2020 | - | $101.78 M(+1.5%) |
| Mar 2020 | - | $100.28 M(+15.4%) |
| Dec 2019 | $86.87 M(+46.0%) | $86.87 M(+0.4%) |
| Sep 2019 | - | $86.51 M(+0.3%) |
| Jun 2019 | - | $86.24 M(+44.4%) |
| Mar 2019 | - | $59.74 M(+0.4%) |
| Dec 2018 | $59.48 M(+2.1%) | $59.48 M(+0.4%) |
| Sep 2018 | - | $59.25 M(+0.3%) |
| Jun 2018 | - | $59.08 M(+0.7%) |
| Mar 2018 | - | $58.67 M(+0.7%) |
| Dec 2017 | $58.25 M | $58.25 M(+25.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $46.48 M(+12.5%) |
| Jun 2017 | - | $41.31 M(+168.3%) |
| Mar 2017 | - | $15.40 M(-9.0%) |
| Dec 2016 | $16.92 M(-9.4%) | $16.92 M(-8.2%) |
| Sep 2016 | - | $18.44 M(-18.9%) |
| Jun 2016 | - | $22.74 M(+21.2%) |
| Mar 2016 | - | $18.76 M(+0.5%) |
| Dec 2015 | $18.68 M(+11.1%) | $18.68 M(+0.4%) |
| Sep 2015 | - | $18.61 M(+9.0%) |
| Jun 2015 | - | $17.08 M(+2.2%) |
| Mar 2015 | - | $16.71 M(-0.6%) |
| Dec 2014 | $16.82 M(+149.2%) | $16.82 M(+41.0%) |
| Sep 2014 | - | $11.92 M(+1.2%) |
| Jun 2014 | - | $11.78 M(+0.3%) |
| Mar 2014 | - | $11.74 M(+74.0%) |
| Dec 2013 | $6.75 M(+56.4%) | $6.75 M(-2.5%) |
| Sep 2013 | - | $6.92 M(-0.2%) |
| Jun 2013 | - | $6.93 M(+30.4%) |
| Mar 2013 | - | $5.32 M(+23.2%) |
| Dec 2012 | $4.31 M(>+9900.0%) | $4.31 M(+1913.3%) |
| Sep 2012 | - | $214.30 K(-3.7%) |
| Jun 2012 | - | $222.50 K(-3.6%) |
| Mar 2012 | - | $230.90 K(>+9900.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00 |
| Jun 2010 | $0.00 | - |
FAQ
- What is ADMA Biologics annual total long term liabilities?
- What is the all time high annual total long term liabilities for ADMA Biologics?
- What is ADMA Biologics annual total long term liabilities year-on-year change?
- What is ADMA Biologics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ADMA Biologics?
- What is ADMA Biologics quarterly long term liabilities year-on-year change?
What is ADMA Biologics annual total long term liabilities?
The current annual total long term liabilities of ADMA is $84.12 M
What is the all time high annual total long term liabilities for ADMA Biologics?
ADMA Biologics all-time high annual total long term liabilities is $157.22 M
What is ADMA Biologics annual total long term liabilities year-on-year change?
Over the past year, ADMA annual total long term liabilities has changed by -$60.05 M (-41.65%)
What is ADMA Biologics quarterly total long term liabilities?
The current quarterly long term liabilities of ADMA is $84.12 M
What is the all time high quarterly long term liabilities for ADMA Biologics?
ADMA Biologics all-time high quarterly total long term liabilities is $158.41 M
What is ADMA Biologics quarterly long term liabilities year-on-year change?
Over the past year, ADMA quarterly total long term liabilities has changed by $0.00 (0.00%)